Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker PTGX
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 58,629 | $8.3M | 10b5-1 | Sep 30, 2026 | — | Form 144 ↗ |
| Aug 10, 2026 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 225,000 | $33.6M | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| Jun 23, 2026 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 9,000 | $1.0M | 10b5-1 | Jun 23, 2026 | Form 4 ↗ 2 days later · 9,000 shares | Form 144 ↗ |
| Jun 10, 2026 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 9,000 | $952.8K | 10b5-1 | Jun 10, 2026 | Form 4 ↗ 1 day later · 9,000 shares | Form 144 ↗ |
| May 29, 2026 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 9,000 | $903.7K | 10b5-1 | May 29, 2026 | Form 4 ↗ 3 days later · 9,000 shares | Form 144 ↗ |
| May 12, 2026 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 75,000 | $7.8M | 10b5-1 | May 12, 2026 | Form 4 ↗ same day · 75,000 shares | Form 144 ↗ |
| May 8, 2026 | Bryan M & Courtney L Giraudo RT Director | PTGX Protagonist Therapeutics, Inc. | 11,130 | $1.1M | — | May 8, 2026 | Form 4 ↗ 3 days later · 59,130 shares | Form 144 ↗ |
| May 7, 2026 | Bryan Giraudo Director | PTGX Protagonist Therapeutics, Inc. | 36,000 | $3.6M | — | May 7, 2026 | Form 4 ↗ 4 days later · 59,130 shares | Form 144 ↗ |
| May 7, 2026 | Bryan M & Courtney L Giraudo RT Director | PTGX Protagonist Therapeutics, Inc. | 12,000 | $1.2M | — | May 7, 2026 | Form 4 ↗ 4 days later · 59,130 shares | Form 144 ↗ |
| Apr 21, 2026 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 1,750 | $184.6K | — | Apr 20, 2026 | Form 4 ↗ same day · 1,750 shares | Form 144 ↗ |
| Mar 26, 2026 | Harold Selick Director | PTGX Protagonist Therapeutics, Inc. | 24,000 | $2.5M | — | Mar 26, 2026 | Form 4 ↗ 1 day later · 24,000 shares | Form 144 ↗ |
| Mar 26, 2026 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 24,765 | $2.6M | — | Mar 26, 2026 | Form 4 ↗ 1 day later · 24,765 shares | Form 144 ↗ |
| Mar 26, 2026 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 15,000 | $1.6M | — | Mar 26, 2026 | Form 4 ↗ 1 day later · 15,000 shares | Form 144 ↗ |
| Mar 24, 2026 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 54,700 | $5.4M | — | Mar 24, 2026 | Form 4 ↗ 1 day later · 54,700 shares | Form 144 ↗ |
| Feb 17, 2026 | Lewis T Williams Director | PTGX Protagonist Therapeutics, Inc. | 18,000 | $1.5M | — | Feb 17, 2026 | Form 4 ↗ 1 day later · 18,000 shares | Form 144 ↗ |
| Feb 6, 2026 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 20,000 | $1.7M | — | Feb 6, 2026 | Form 4 ↗ same day · 20,000 shares | Form 144 ↗ |
| Jan 27, 2026 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 46,203 | $3.8M | — | Jan 27, 2026 | Form 4 ↗ same day · 46,203 shares | Form 144 ↗ |
| Jan 27, 2026 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 5,000 | $410.0K | — | Jan 27, 2026 | Form 4 ↗ same day · 10,000 shares | Form 144 ↗ |
| Jan 26, 2026 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 5,000 | $411.4K | — | Jan 26, 2026 | Form 4 ↗ 1 day later · 23,151 shares | Form 144 ↗ |
| Jan 23, 2026 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 108,273 | $9.2M | — | Jan 23, 2026 | Form 4 ↗ 4 days later · 48,273 shares | Form 144 ↗ |
| Jan 23, 2026 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 13,151 | $1.1M | — | Jan 23, 2026 | Form 4 ↗ 4 days later · 23,151 shares | Form 144 ↗ |
| Jan 21, 2026 | Arturo Molina MD Officer | PTGX Protagonist Therapeutics, Inc. | 9,514 | $784.7K | — | Jan 20, 2026 | Form 4 ↗ 6 days later · 23,151 shares | Form 144 ↗ |
| Jan 21, 2026 | Dinesh V Patel PH D Officer, Director | PTGX Protagonist Therapeutics, Inc. | 34,438 | $2.8M | — | Jan 20, 2026 | Form 4 ↗ 6 days later · 48,273 shares | Form 144 ↗ |
| Jan 21, 2026 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 8,588 | $708.3K | — | Jan 20, 2026 | Form 4 ↗ 6 days later · 46,203 shares | Form 144 ↗ |
| Oct 10, 2025 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 12,000 | $804.5K | 10b5-1 | Oct 10, 2025 | Form 4 ↗ 4 days later · 12,000 shares | Form 144 ↗ |
| Sep 22, 2025 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 4,000 | $248.8K | 10b5-1 | Sep 22, 2025 | Form 4 ↗ 2 days later · 4,000 shares | Form 144 ↗ |
| Aug 27, 2025 | William Waddill Director | PTGX Protagonist Therapeutics, Inc. | 4,000 | $228.0K | 10b5-1 | Aug 27, 2025 | Form 4 ↗ 2 days later · 4,000 shares | Form 144 ↗ |
| Jul 22, 2025 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 50,000 | $2.8M | — | Jul 22, 2025 | Form 4 ↗ 1 day later · 52,444 shares | Form 144 ↗ |
| Jun 10, 2025 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 10,000 | $570.3K | — | Jun 10, 2025 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Jun 9, 2025 | Arturo Molina Officer | PTGX Protagonist Therapeutics, Inc. | 10,000 | $555.1K | — | Jun 9, 2025 | Form 4 ↗ 2 days later · 20,000 shares | Form 144 ↗ |
| Mar 17, 2025 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 4,000 | $219.1K | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 2 days later · 4,000 shares | Form 144 ↗ |
| Mar 13, 2025 | Molina Arturo MD Officer | PTGX Protagonist Therapeutics, Inc. | 30,514 | $1.7M | — | Mar 13, 2025 | Form 4 ↗ 1 day later · 30,514 shares | Form 144 ↗ |
| Mar 12, 2025 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 24,903 | $1.5M | — | Mar 12, 2025 | Form 4 ↗ 2 days later · 24,903 shares | Form 144 ↗ |
| Nov 27, 2024 | Molina Arturo MD Officer | PTGX Protagonist Therapeutics, Inc. | 16,000 | $704.0K | — | Nov 27, 2024 | Form 4 ↗ same day · 31,529 shares | Form 144 ↗ |
| Nov 26, 2024 | Molina Arturo MD Officer | PTGX Protagonist Therapeutics, Inc. | 16,000 | $720.0K | — | Nov 26, 2024 | Form 4 ↗ 1 day later · 31,529 shares | Form 144 ↗ |
| Nov 26, 2024 | Gupta Suneel Officer | PTGX Protagonist Therapeutics, Inc. | 19,191 | $873.2K | — | Nov 26, 2024 | Form 4 ↗ 1 day later · 122,628 shares | Form 144 ↗ |
| Nov 25, 2024 | Gupta Suneel Officer | PTGX Protagonist Therapeutics, Inc. | 103,437 | $4.8M | — | Nov 25, 2024 | Form 4 ↗ 2 days later · 122,628 shares | Form 144 ↗ |
| Nov 25, 2024 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 100,000 | $4.6M | 10b5-1 | Nov 25, 2024 | Form 4 ↗ 2 days later · 100,000 shares | Form 144 ↗ |
| Sep 11, 2024 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 14,203 | $631.9K | — | Sep 11, 2024 | — | Form 144 ↗ |
| Sep 10, 2024 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 8,000 | $360.0K | 10b5-1 | Sep 10, 2024 | — | Form 144 ↗ |
| Jul 24, 2024 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 8,000 | $320.0K | 10b5-1 | Jul 24, 2024 | — | Form 144 ↗ |
| Jun 7, 2024 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 35,000 | $1.2M | 10b5-1 | Jun 7, 2024 | — | Form 144 ↗ |
| Jun 7, 2024 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 8,000 | $280.0K | 10b5-1 | Jun 7, 2024 | — | Form 144 ↗ |
| Apr 1, 2024 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 25,000 | $719.3K | 10b5-1 | Apr 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 14,248 | $459.3K | — | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 90,000 | $2.8M | 10b5-1 | Mar 1, 2024 | — | Form 144 ↗ |
| Mar 1, 2024 | William D Waddill Director | PTGX Protagonist Therapeutics, Inc. | 12,975 | $406.6K | 10b5-1 | Mar 1, 2024 | — | Form 144 ↗ |
| Feb 29, 2024 | Ali Asif Officer | PTGX Protagonist Therapeutics, Inc. | 9,939 | $305.0K | — | Feb 29, 2024 | — | Form 144 ↗ |
| Jan 9, 2024 | Suneel Gupta Officer | PTGX Protagonist Therapeutics, Inc. | 5,000 | $125.0K | 10b5-1 | Jan 9, 2024 | — | Form 144 ↗ |
| Dec 13, 2023 | Dinesh Patel CEO | PTGX Protagonist Therapeutics, Inc. | 75,000 | $1.5M | 10b5-1 | Dec 13, 2023 | — | Form 144 ↗ |
50 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:06 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances